A great day to celebrate!
About us
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs.
- Website
-
https://evozyne.com/
External link for Evozyne
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
Get directions
Chicago, IL, US
Employees at Evozyne
Updates
-
On National Doctors' Day, Evozyne recognizes the significant contributions physicians have made to improve lives and communities across the country. With nearly 48,000 active physicians in the Illinois and 1.1M active physicians in the U.S., doctors play a pivotal role in maintaining and enhancing the health of our nation. #doctorsday
-
-
Today, we honor the life and legacy of Dr. Martin Luther King, Jr. His dream of a united, compassionate world where kindness prevails, and equality thrives continues to live on. #martinlutherkingjr
-
Great news to start 2024! Biotech veteran Marc Yoskowitz joins Evozyne as our new CEO. He will be leading Evozyne as we focus on drug discovery through our generative AI platform. Read more: https://lnkd.in/g2_bnHCF #ceo
-
-
Evozyne was recently featured in Chicago NBC 5 news story on AI drug development. The segment, featuring CEO Mike Gamson, highlighted the potential of AI to expedite new therapies and cures for those who need it the most, saving time, money and potentially lives. Check it out: https://lnkd.in/gJcJHnEg #ai #drugdevelopment
-
Today, we closed an $81 million raise that will fund our generative AI-powered drug discovery platform and product development. This dovetails with our successful collaboration with NVIDIA earlier this year that resulted in a breakthrough AI model that can be used to design therapeutic proteins. Read more here: https://lnkd.in/gRN7W5kc
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development | Evozyne
evozyne.com